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Abstract
The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in
biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We
have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also
an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA)
significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on
C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control
compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of
biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas
chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The
mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to
HICA (p,0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for
4 h at neutral pH. Mutagenic levels (.40 mM) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no
ACH production was detected from D-glucose in the presence of HICA at acidic pH (p,0.05). Expression of genes
responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant
hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as
an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the
mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.
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Introduction
C. albicans is the most common fungal pathogen in humans
causing both superficial and systemic infections [1]. The ability of
C. albicans to form biofilms is a major virulence factor and
approximately 65% of microbial infections in humans are biofilm-
related [2,3]. This mode of growth protects Candida spp. against
endogenous and exogenous inhibitory substances. High antifungal
tolerance is a well-known factor of Candida biofilms and a challenge
for treatment [4]. The surrounding environment and its cues have
a major impact on C. albicans biofilm formation. Hyphal growth is
an essential element of C. albicans biofilms that provides integrity
within these complex and dense structures [5,6]. Multiple studies
have shown that environmental pH, oxygen levels and nutritional
status impact on the morphogenesis of C. albicans [7–10].
Chronic biofilm infections cause inflammation, which is linked
to carcinogenesis [11]. Biofilm related chronic mucocutaneous
candidosis (CMC) has been associated with a significant risk for
oral cancer in vivo [12–14]. C. albicans isolated from these patients
are able to produce high levels of carcinogenic acetaldehyde
(ACH) in vitro thus providing one possible explanation for
carcinogenesis [15]. The International Agency for Research on
Cancer (IARC) has classified ACH associated with alcoholic
beverages as a GROUP I carcinogen [16]. Our group has
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previously shown that planktonically grown Candida spp. can
produce significant and mutagenic levels of ACH (.40 mM) as
part of their ethanol metabolism in vitro [17,18]. ACH is an
intermediate product of the pyruvate bypass pathway that converts
pyruvate into acetyl-CoA in the cytosol under low oxygen tension
or anaerobic conditions during fermentation (Fig. 1A; [19]). In
bypass, pyruvate is first converted to ACH by pyruvate
decarboxylase (Pdc) and then ACH is metabolized either to
acetate by aldehyde dehydrogenases (Ald) or turned into ethanol
by alcohol dehydrogenase (Adh) enzymes. Acetate is further
metabolized to acetyl-CoA by acetyl CoA synthetase (Acs)
enzymes and transported into mitochondria by a carnitine
dependent mechanism.
Genomic databases show that there are five putative genes
encoding Adh enzymes for C. albicans [20]. ADH1 encodes a
cytosolic Adh1p enzyme that is the only isoenzyme studied
extensively and the protein is able to function bi-directionally in
ACH-ethanol conversion thus making the use of ethanol as a
carbon and energy source possible [21]. Proteomic and transcrip-
tional studies have shown that ADH1 is one of the factors that
controls biofilm formation and growth [22,23]. Recently more
information has been revealed about other Adh isoenzymes. In S.
cerevisiae Adh2p functions in glucose-depleted conditions, and
converts ethanol to ACH in vitro [24]. In C. albicans, ADH2 is
upregulated in planktonic cells grown in hypoxic conditions and
mainly in the stationary growth phase [8,25]. ADH5 has a role in
controlling the biofilm matrix formation in C. albicans [26].
The number and role of Ald enzymes in C. albicans are not well
known, but in S. cerevisiae there are five known genes [27]. The
mitochondrial isoforms in S. cerevisiae are encoded by ALD4 (major)
and ALD5. The cytosolic counterparts are encoded by ALD2,
ALD3 and ALD6 (major). In C. albicans, the protein encoded by
ALD4 is known to function in carnitine biosynthesis in the cytosol
[28]. The carnitine biosynthesis and carnitine-dependent trans-
formation of Acetyl-CoA are vital for growth on non-fermentable
carbon sources and contribute to biofilm formation [29]. ALD5 is
upregulated in C. albicans biofilms exposed to oxidative stress and
hypoxia [30–32]. Our group has shown that ALD6 together with
ACS1 control the accumulation of ACH in planktonic C. albicans
cultures in hypoxia [25]. Acs enzymes have been studied
extensively in C. albicans. ACS2 is essential for growth and ACS1
is necessary for utilization of alternative carbon sources [33].
Recent studies show that proteins linked to fermentation are
abundant in hyphae and biofilms [30,34,35]. Upregulation of
fermentation has been shown in C. albicans colonization in vivo [36].
Altogether, these facts underline the importance of pyruvate
bypass genes and fermentation for biofilm formation.
Poor efficacy and patient compliance and various side effects of
commonly used antifungals have been major problems in the
management of Candida infections [1]. The most promising
chemotherapeutic approaches against Candida biofilms are ob-
served with the echinocandin class of antifungals, which are non-
competitive inhibitors of (1,3)-b-D-glucan synthase, an essential
enzyme in cell wall synthesis and integrity [37,38]. Caspofungin is
the most extensively used echinocandin, especially in treatment for
invasive candidosis [39,40]. Although caspofungin has proven
effective against C. albicans biofilms, a paradoxical effect on growth
by induction of chitin synthesis and decreased susceptibility have
been noted, suggesting there are limitations in its use [41,42].
Recent studies from our group show promising efficacy of D,L-
2-hydroxyisocaproic acid (HICA) against the growth of a spectrum
of planktonically grown pathogenic bacteria and fungi including C.
albicans, C. glabrata and C. tropicalis [43,44]. HICA is a a-hydroxy-
aminoacid and a leucine metabolite, which is produced by
Figure 1. Relative expression of genes related to ACH metabolism. (A) A schematic model of central carbon metabolism incorporated with
genes of interest within ethanol metabolism (abbreviations as follows: G6P= glucose-6-phosphate, KICA= a-ketoisocaproic acid). (B) Heat map panel
of gene expression in C. albicans biofilms at three different stages of growth at pH 5.2 and 7.4 after 24 h exposure to PBS, caspofungin, HICA, leucine,
cysteine or ethanol. Fold changes are expressed relative to control (RPMI) at the corresponding time point. Black represents no change in expression,
green is up-regulation, and red is down-regulation. A brighter color indicates greater degree of change in expression. Relative gene expressions were
calculated by the Pfaffl method using the REST 2009 software provided by Qiagen [63].
doi:10.1371/journal.pone.0097864.g001
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Lactobacillus species and also found in human muscle and
connective tissues [45–47]. It has been used as a nutritional
supplement by professional athletes and industrially as animal
feeds [47,48]. Therefore it is proven to have a good biocompat-
ibility and safety profile. In addition, there is evidence that HICA
has anti-inflammatory properties through inhibition of host
extracellular matrix degrading proteases in vitro [49]. Multiple
studies have shown that Lactobacillus spp. metabolites which are
similar to HICA and other amino acid derivatives inhibit fungal
growth [45,50–52].
In this study our aim was to determine the ability of HICA to
inhibit biofilm formation and to reduce the mutagenic potential of
C. albicans biofilms through changes in ACH metabolism in vitro.
We also wanted to show visually the impact of HICA on biofilm
ultrastructure and examine further the effect of caspofungin and
HICA-related carbon sources on biofilm formation and ACH
metabolism. Our hypothesis is that the formation of C. albicans
biofilms is strongly reduced and damaged by HICA and
furthermore the mutagenic potential is significantly decreased by
the induction of genes involved in pyruvate bypass and ACH
metabolism.
Materials and Methods
Study design
Biofilms were grown on coverslips in RPMI medium at 37uC at
pH 7.4 for 4, 24 and 48 h (Fig. 2; [53,54]). Pre-grown biofilms
were exposed to HICA, leucine, cysteine or ethanol for 24 h at
pH 5.2 or pH 7.4. Leucine was included as a metabolic
comparator. Cysteine is toxic to fungi in high concentrations
similar to HICA and was included as a comparator. Ethanol is the
end product of fermentation and main source of ACH.
Caspofungin was used as an antifungal comparator, and PBS
and RPMI as controls. Five different methods were used to
evaluate the effects of these substances on C. albicans biofilm
formation and mutagenic properties.
XTT assay was used to determine cellular metabolism, and the
amount of double stranded DNA (dsDNA) was used to reflect
biofilm biomass [55–58]. ACH production in glucose or ethanol
was measured by gas chromatography. To detect changes in ACH
metabolism, gene expression of seven target genes (ADH1, ADH2,
ACS1, ACS2, ALD4, ALD5 and ALD6) and one reference gene
(RIP1) was analyzed by quantitative real time PCR (RT-qPCR).
Scanning electron microscopy (SEM) was used to visualize the
impact of HICA on biofilm structure. All experiments were done
twice in triplicate. In total 1,300 biofilms were used in the study.
Strain and culture conditions
C. albicans laboratory strain SC5314 was used [20,59]. The
strain was stored at 280uC and plated twice on Sabouraud
dextrose agar (Melford, UK) and incubated at 37uC for 48 h
before use to check viability and purity. One colony was then
inoculated into 20 ml yeast peptone dextrose (YPD) broth
(Melford, UK) and grown overnight at 37uC with continuous
shaking. The cells were harvested, washed twice with sterile
phosphate-buffered saline (PBS) (Sigma-Aldrich, USA) and then
re-suspended in RPMI-1640 (Sigma-Aldrich) supplemented with
L-glutamine and buffered to pH 7.4 with morpholinepropanesul-
fonic acid (MOPS) (Oxoid Ltd., UK). The cell density was
measured using a haemocytometer and adjusted to 1.06106 cells/
ml to produce the standardized biofilm inoculum.
Biofilm growth and treatments
C. albicans biofilms were grown on Thermanox coverslips
(Thermo Scientific Nunc, USA) in RPMI-1640 medium contain-
ing 2 g/l D-glucose (#6504; Sigma-Aldrich, USA) at pH 7.4 in
static 24-well plates (Corning CoStar, USA) for 4, 24 or 48 h at
37uC. The biofilms were then exposed to 5% (w/v) HICA (TCI
Europe, Belgium), 10 mg/l caspofungin (Merck & Co., USA), 5%
(w/v) leucine (L-leucine Sigma-Aldrich, USA), 5% (w/v) cysteine
(L-cysteine, Sigma-Aldrich, USA), 0.05% (v/v; 11 mM) ethanol,
PBS or RPMI-1640 #6504 for 24 h at pH 5.2 or 7.4 at 37uC.
Substrates were dissolved in RPMI-1640 #6504 except for the
ethanol treatment, which was dissolved in RPMI-1640 #1383
without D-glucose or sodium bicarbonate and then adjusted to
pH 5.2 or 7.4.
XTT-assay and dsDNA measurements
Before analysis, biofilms were washed with sterile PBS and then
transferred into fresh 24-well plates. Then 200 ml saturated XTT/
1 mM menadione solution was added to the biofilms, the plates
covered with aluminium foil and transferred to a 37uC incubator
for 2 h. After incubation, 100 ml of the XTT supernatant was
transferred into fresh 96-well plates and the colorimetric changes
were measured spectrophotometrically (BMG Labtech, UK) at
490 nm.
Fluorescent nucleic acid Quant-iT PicoGreen dsDNA reagent
(Molecular Probes Inc., USA) was used for quantifying dsDNA in
solution. Briefly, DNA was extracted from the biofilms using a
modified cetyltrimethylammonium bromide (CTAB) method [60].
The DNA and PicoGreen reagent were mixed thoroughly in the
well before fluorometric analysis at 492 nm (BMG Labtech, UK).
The lambda DNA within the Quant-iT kit was used to construct
the standard curve (concentration range 40–500 ng/ml) according
to the manufacturer’s instructions and measured alongside the
samples (100 ml per well; Corning Costar, UK).
Acetaldehyde measurements
ACH production was measured by headspace gas chromatog-
raphy using a previously described method [18]. Briefly, gas
chromatography was performed with a Varian CP-3800 equipped
with a Zebron ZB-WaxPlus column (30 mx0.32 mmx0.5 mm,
Phenomenex, UK), and CombiPal autosampler (CTC Analytics
GmbH, Germany). Peaks were detected by flame ionization.
Figure 2. Summary of study design.
doi:10.1371/journal.pone.0097864.g002
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Biofilms were washed once with PBS post-exposure (24 h in 5%
(w/v) HICA, 0.05% (v/v) ethanol, 10 mg/l caspofungin or RPMI)
and transferred into 20 ml glass vials containing 1 ml 11 mM
(0.05% (v/v)) ethanol, 100 mM (1.8% (w/v)) D-glucose or PBS
(control). The samples were sealed with silicon caps and incubated
at 37uC for 30 min. The reaction was stopped by the addition of
100 ml of perchloric acid (PCA, final concentration 0.6 M). To
measure baseline or artefactual ACH production, 100 ml PCA was
added immediately after transferring the biofilms into vials and
prior to adding ethanol, D-glucose or PBS substrate.
Gene expression analysis
Exposed biofilms were flash-frozen in liquid nitrogen, then
stored at 280uC until RNA extraction. Biofilms were detached by
vortexing and then homogenized using glass beads (425–600 mm
in diameter; Sigma, UK) and a FastPrep Instrument (MP
Biomedical, USA). The samples were centrifuged at RT for
1 min at 12,000 g after the FastPrep step. RNA extractions were
performed using the ISOLATE I RNA Mini kit (Bioline, UK) and
genomic DNA was removed using Ambion DNA-free DNAse (Life
Technologies, UK) treatment according to the manufacturer’s
instructions. RNA was quantified and quality assessed by
spectroscopy (A260nm) and the purity was further determined by
RT-qPCR and gel electrophoresis. RNA was stored at 280uC for
further analysis.
cDNA was synthesized using the AffinityScript QPCR cDNA
synthesis kit (Agilent, UK) following the manufacturer’s directions
using 6 ml of RNA (10 ng/ml) as a template. In no-RT controls
reverse transcriptase was replaced by water. Reverse transcription
was carried out at 25uC for 5 min, then at 42uC for 60 min and
finally at 95uC for 5 min. RT-qPCR reactions were prepared
using the Brilliant II SYBR Green 2-step kit (Agilent, UK) with the
reaction containing 6.25 ml SYBR Green master mix, 1 ml
Forward (F) primer, 1 ml Reverse (R) primer, 2 ml cDNA and
2.25 ml DNA/RNA-free molecular grade water. PCR was
performed with a Stratagene MX3005P instrument (Agilent,
UK). For all RT-qPCR experiments, primers were designed using
Primer 3.0 Plus [61] and are shown in Table S1. RIP1 was used as
a reference gene [62]. The results shown are an average of
triplicates from two independent biological samples. The PCR
amplification efficiencies of the primers for all target genes were
optimized prior to analysis. The relative gene expression was
calculated by the Pfaffl method using the REST 2009 software
provided by Qiagen [63]. The gene expression results were
compiled to a heatmap using Microsoft Excel 2010 ver. 14.0.
Scanning electron microscopy of in vitro biofilms
Biofilms were grown in RPMI as previously described for 24 h
and then exposed to 5% (w/v) HICA or RPMI #6504 (control)
for 24 h at pH 5.2 or pH 7.4. The biofilms were washed once with
PBS before being placed in fixative (2% (v/v) paraformaldehyde,
2% (v/v) glutaraldehyde, 0.15 mM sodium cacodylate and 0.15%
(w/v) Alcian blue in PBS) overnight as previously described [64].
Biofilms were then rinsed in 0.1 M phosphate buffer and air-dried
in desiccators. Notably, harsh dehydration steps were not
performed to minimize the damage to the original biofilm
structure. The samples were coated with gold/palladium (40%/
60%) and observed under a scanning electron microscope (Leo
435 VP) in high vacuum mode at 10 kV.
Statistical analysis
Statistical analyses for XTT, PicoGreen and ACH measure-
ments were carried out using GraphPad Prism ver. 5.0 (GraphPad
Software Inc., La Jolla, CA, USA) and SPSS ver. 18.0 (SPSS Inc.,
Chicago, IL, USA). A generalised estimating equations (GEE)
model was used for comparisons of XTT, PicoGreen and ACH
results. Statistical comparisons for gene expression analyses were
performed using a pair-wise fixed reallocation test within REST
2009 software (Qiagen, CA, USA). P,0.05 was considered
statistically significant. Basal transcription of genes in each
condition was calculated relative to the reference gene, RIP1,
using equation 22DCt (DCt=CtTreatment-CtReference). A 2-tailed
Spearman’s rho (rs) with a 95% confidence interval was used for
the analyses of correlations. Basal expression levels were used for
the analyses of correlations. The results are expressed as means
(6SEM).
Results
HICA has a significant inhibitory effect on biofilm
formation at acidic pH
At acidic pH, the metabolic activity (MA) of all pre-grown
biofilms was significantly reduced by HICA exposure (Fig. 3A; 4,
24 and 48 h, p,0.001): MA was reduced by 59–81% compared to
RPMI at pH 5.2. A maximum drop of 81% in MA was measured
in 4 h biofilms post-exposure to HICA (OD492; 0.4360.01 vs.
2.2460.06 in RPMI). MA was reduced in all pre-formed biofilms
under all treatment conditions except for exposure to cysteine,
which had no effect on the MA of 48 h biofilms. Similar levels of
MA were measured for 4, 24, and 48 h biofilms in the control
condition, RPMI (Fig. 3A, B).
At neutral pH, MA was reduced in all pre-formed biofilms
compared to RPMI, except after exposure to cysteine and leucine
where an increase was observed in 24 and 48 h biofilms (Fig. 3B).
Caspofungin exposure had the greatest negative impact on MA of
all conditions in 4 h biofilms (OD492 0.5660.06 vs. 2.0960.03 in
RPMI, p,0.001), but a much lower reduction was seen in 24 and
48 h biofilms. MA was lower by 12–32% and the reduction was
highly significant in all pre-formed biofilms after exposure to
HICA (p,0.001).
Biofilm biomass was significantly decreased after all treatments
in all biofilms pre-grown for 4, 24 and 48 h at pH 5.2, except after
exposure to caspofungin (Fig. 3C; 0.001,p,0.05). Leucine
exposure increased the biomass of 48 h biofilms, but this change
was not statistically significant (p = ns). Biomass was greatly
affected by HICA and cysteine exposure at acidic pH (overall
reduction was by 62% and 63%, respectively). The greatest
reduction in biomass (80%) was observed in 4 h biofilms after
exposure to HICA (dsDNA conc. 33.465.6 ng/ml vs.
169.165.7 ng/ml in RPMI). Caspofungin had no significant effect
on biomass at pH 5.2, with the highest reduction being only 2%
measured in 24 h pre-formed biofilms (221.5639.8 ng/ml vs.
226.168.2 ng/ml in RPMI). Biomass of pre-grown biofilms was
reduced by 42% post-exposure to PBS.
Upon exposure to PBS, HICA, cysteine or ethanol at neutral
pH, biofilm biomass was reduced significantly in 4 and 24 h pre-
formed biofilms (Fig. 3D, 0.001,p,0.05). Exposure to caspofun-
gin or leucine had no discernable effect on biomass of any pre-
grown biofilms. The biomass of 4 h and 24 h pre-formed biofilms
was reduced by 27% and 19% respectively after exposure to
HICA when compared to RPMI (Fig. 3D; 127.668.9 ng/ml and
146.2611.9 ng/ml vs. 174.967.1 ng/ml and 181.567.7 ng/ml
respectively). Leucine exposure had a significant effect only on
48 h biofilm biomass, which was increased by 53% (p,0.001;
306.1617.0 ng/ml vs. 200.1617.7 ng/ml respectively).
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Acetaldehyde catabolism was induced in biofilms
exposed to HICA at acidic pH
High basal expression (relative to the reference gene, RIP1) of
ADH1, ADH2 and ALD5 in pre-formed biofilms exposed to pH 5.2
suggested that expression of these genes was indicative of
significant biological function in the biofilm. ALD4, ALD6, ACS1
and ACS2 were expressed at very low basal level, therefore changes
in expressions of these genes should be treated with caution. ALD5
was highly expressed in all pre-formed biofilms after all exposures
including the RPMI control. ADH1 was also highly expressed with
respect to the reference gene in 4 and 48 h biofilms, but not to the
same extent in 24 h biofilms. High ADH1 expression was
correlated with high ADH2 expression in the following conditions:
4 h biofilms exposed to cysteine, leucine or PBS and 48 h biofilms
exposed to cysteine or HICA.
When relative gene expression was compared, between
treatment and control conditions, ADH1 was found to be up-
regulated 1.8–2.1 fold after HICA exposure and down-regulated
by 0.2–0.3 fold after caspofungin exposure in 4 and 48 h pre-
formed biofilms (Fig. 1B). In addition, ALD5 was significantly
down-regulated in all pre-formed biofilms after caspofungin and
ethanol exposure (0.3–0.8 fold), but not affected by exposure to
HICA. Generally, ACS1 was down-regulated (0.02 to 0.4 fold) in 4
and 48 h pre-formed biofilms after caspofungin exposure but up-
regulated (2 to 4 fold) after HICA exposure. Cysteine exposure
resulted in induced expression of all genes in 48 h pre-formed
biofilms.
Acetaldehyde catabolism was also induced in biofilms
exposed to HICA at neutral pH
The high basal expression of ALD5 observed in biofilms at
pH 5.2 was also observed in all pre-formed biofilms grown at
pH 7.4, for all exposures including RPMI control biofilms. Overall
a decrease in transcription rates in biofilms at later stages of
development was observed at neutral pH compared to transcrip-
tion rates at acidic pH. Unlike basal transcription at pH 5.2,
ADH1 and ADH2 were generally poorly expressed at pH 7.4.
When biofilm gene expression was compared relative to the
biofilm controls (RPMI), more up-regulation was observed in
biofilms exposed to HICA than in biofilms exposed to caspofungin
(pH 7.4, Fig. 1B). In general, heatmaps for biofilms exposed to
leucine, ethanol and cysteine showed a similar pattern to that of
HICA, except for expression of ALD5 and ACS1. Cysteine and
leucine exposure led to higher expression of ALD5 and ACS1 in
later biofilms compared to HICA and caspofungin.
Mutagenic potential of C. albicans biofilms is reduced by
HICA at acidic and neutral pH
Generally, the highest ACH production was observed in control
biofilms (RPMI); this was evident after incubation in 0.05%
ethanol (Fig. 4C, D; 135.265.7 mM at 24 h, pH 5.2 and
130.3612.3 mM at 48 h, pH 7.4). In D-glucose, ACH levels for
biofilms exposed to RPMI were markedly lower but still above the
mutagenic level of 40 mM at neutral pH (Fig. 4B; 53.861.9 mM at
48 h). No ACH was detected in any condition or pH when
biofilms were incubated with PBS.
Figure 3. Changes in metabolic activity and biomass of C. albicans biofilms. Metabolic activities measured by XTT-assay (panel A, B) and
dsDNA levels (panel C, D) reflecting the biomass of C. albicans biofilms at pH 5.2 and 7.4. Biofilms were grown for 4, 24 or 48 h in RPMI at pH 7.4 and
then exposed to PBS, caspofungin, HICA, leucine, cysteine or ethanol for another 24 h. Values were measured twice in triplicate and expressed as
mean (6SEM). Means were compared to the control treatment (RPMI). Statistically significant differences were calculated using a GEE-model and
were marked (**p,0.001,* 0.001,p,0.05).
doi:10.1371/journal.pone.0097864.g003
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ACH was not detected in biofilms exposed to HICA at acidic
pH after incubation with D-glucose (Fig. 4A). However, under the
same conditions, ACH levels increased significantly compared to
RPMI in 24 h and 48 h pre-grown biofilms after caspofungin
exposure (p = 0.021 and p= 0.01, respectively), with the highest
ACH production detected in 48 h biofilms (Fig. 4A;
41.367.5 mM). Generally, low production of ACH from D-
glucose was observed in pre-grown biofilms exposed to ethanol at
both pHs, compared to control biofilms (Fig. 4A, B).
At neutral pH no ACH was produced during incubation with
D-glucose by biofilms pre-grown for 4 h and exposed to
caspofungin compared to all other exposures, including the
control (RPMI). However, ACH production among 24 h and
48 h pre-formed biofilms exposed to caspofungin, HICA or
ethanol was similar but significantly lower than in control biofilms
(p,0.001, Fig. 4B). Equivalent levels of ACH were produced from
ethanol by biofilms exposed to RPMI and ethanol at acidic pH
(Fig. 4C). HICA or caspofungin exposure reduced the ACH
production from ethanol in 4 and 24 h but not 48 h pre-formed
biofilms at pH 5.2 (Fig. 4C, p,0.05). At neutral pH, HICA or
caspofungin exposure led to significantly lower ACH production
from ethanol in 24 and 48 h pre-formed biofilms (Fig. 4D; p,
0.001). Although caspofungin exposure also decreased ACH
production in 4 h pre-formed biofilms under these conditions,
this was not the case after HICA exposure. In ethanol incubation
ACH levels were generally above the mutagenic level (40 mM) at
both pHs, although reductions close to this level were seen with
HICA and caspofungin.
Gene expression reflected the changes in ACH levels
Correlations were calculated for genes that exhibited a high
basal level of expression (ADH1, ADH2, ALD5). ALD5 expression
correlated with pH in all pre-formed biofilms exposed to HICA
(rs = 0.7257, p,0.001), caspofungin (rs = 0.695, p = 0.0014) and
PBS (rs = 0.501, p= 0.034). In addition, in biofilms exposed to
PBS, expression of both ADH1 and ADH2 correlated significantly
with pH, similar to ALD5 (rs = 0.685, p = 0.0017 for ADH1 and
rs = 0.769, p,0.001 for ADH2, respectively). This implies that
downstream ACH metabolism is controlled similarly at both pHs.
No correlations were observed between gene expression and pH
for other exposure conditions. ADH1 expression correlated
positively with ADH2 expression (rs = 0.703, p,0.001).
Changes in gene expression mirrored the ACH levels at neutral
pH. A negative correlation between ACH levels and ALD5
expression was observed in RPMI biofilms incubated with D-
glucose (rs =20.763, p,0.001). Similar negative correlations were
observed in biofilms exposed to all conditions tested for ACH
production from ethanol (20.769,rs,20.661, 0.001,p,0.003).
In contrast to neutral pH, most of the correlations between gene
expression and ACH levels were not significant at acidic pH. In
RPMI biofilms the ALD5 expression correlated positively with
ACH values after ethanol incubation (rs = 0.746, p,0.001) while
expression of both ADH1 and ADH2 correlated negatively with
ACH values (rs =20.558, p = 0.016 and rs =20.636, p = 0.005
respectively). This suggests a strong induction of pyruvate bypass
towards acetate in RPMI biofilms at acidic pH as expected and
control of pyruvate bypass by downstream metabolism genes, such
as ALD5.
Figure 4. ACH production by C. albicans biofilms. Mean (6SEM) ACH production by C. albicans biofilms. Biofilms at three different stages of
growth (4 h, 24 h and 48 h), were incubated for 30 min at 37uC with 100 mM D-glucose (A,B) or 0.05% ethanol (C,D) after 24 h exposure to RPMI,
ethanol, caspofungin or HICA at pH 5.2 or 7.4. Values were measured twice in triplicate and means were compared at each time point to the control
treatment (RPMI). Statistically significant differences were calculated using a GEE-model and were marked (**p,0.001, * 0.001,p,0.05).
doi:10.1371/journal.pone.0097864.g004
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HICA treatment caused structural defects to intact C.
albicans biofilms
Major defects were observed in biofilm ultrastructure after
exposure to HICA particularly at acidic pH. Hyphal networks had
collapsed and hyphae appeared fractured (Fig. 5A). A similarly
sparse hyphal network was observed at neutral pH (Fig. 5B). In
control images, hyphae appeared intact and unaffected by acidic
pH (Fig. 5C, D). On exposure to HICA, more yeast cells were
observed at neutral pH while hyphal tips showed signs of damage
at acidic pH. Interestingly, when the HICA concentration was
increased, more damaged hyphae were observed at acidic pH and
the yeast cell phenotype was pronounced at neutral pH (figures not
shown).
Discussion
Our study demonstrates a robust efficacy of HICA against C.
albicans biofilms in vitro. Biofilm metabolic activity and biomass
were significantly reduced by HICA especially under acidic
conditions. The effect was visualized by SEM, which showed
collapsing and aberrant hyphal structures in the pre-formed
biofilms after exposure to HICA at both acidic and neutral pH
conditions. There were signs of cell lysis in acidic conditions. A
similar effect has been noted in Aspergillus fumigatus microcolonies in
response to echinocandins [65]. In the present study there was no
reduction of biomass when C. albicans biofilms were exposed to
caspofungin, and the metabolic activity was reduced in early (4 h)
biofilms only. In older biofilms, caspofungin exposure moderately
increased the biofilm biomass thus supporting findings on the
paradoxical effect on growth [41]. The effect of leucine on
biomass, metabolic activity and ACH metabolism was opposite to
that of HICA, and non-inhibitory at neutral pH, suggesting a
different metabolic action. In contrast, cysteine exposure reduced
the biofilm biomass as effectively as HICA at acidic pH, although
no reduction in metabolic activity was observed. Cysteine is vital
for cellular function, but high levels cause accumulation of toxic
sulfite [66]. This is known to be toxic to bacteria and fungi but its
impact on biofilms has not been studied [67–69]. Although a very
low concentration of ethanol (0.05%) was used in this study a
reduction in biofilm biomass of 33% at pH 5.2 and 22% at pH 7.4
was observed. This is of clinical interest as ethanol is used in
antifungal lock therapy against Candida spp. biofilms [70].
In the human body ACH is metabolized into acetate mainly by
the mitochondrial Ald enzyme (ALDH2; [71]). In our study, ALD5
was the only Ald enzyme encoding gene highly expressed in C.
albicans biofilms in all conditions tested. C. albicans ALD5 is an
ortholog of S. cerevisiae ALD5, which encodes the mitochondrial Ald
enzyme [20,72]. Previously our group showed that ALD6,
encoding the cytosolic counterpart, is highly expressed in hypoxic
conditions in planktonically grown cells and the expression
correlated well with ACH levels [25]. In early biofilms exposed
to cysteine and PBS, a mild increase in the basal expression of
ALD6 relative to the reference gene was observed thus supporting
the finding of planktonic cultures (data not shown). There was a
correlation between ACH production and ALD5 expression in our
study. Impairment of pyruvate bypass downstream metabolism by
down-regulation of ALD5 was observed together with high ACH
levels in caspofungin biofilms. ADH1 was also highly expressed but
Figure 5. Microscopic examination of C. albicans biofilms exposed to HICA. SEM images were taken of biofilms which were grown for 24 h in
RPMI at pH 7.4 and then exposed to 5% HICA for another 24 h at pH 5.2 (A) or pH 7.4 (B). Control images were taken of biofilms grown in RPMI-
medium without HICA at pH 5.2 (C) or pH 7.4 (D). Insets show hyphal structures in detail. Scale bars indicate 10 mm in main images and 5 mm in
insets.
doi:10.1371/journal.pone.0097864.g005
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not in all conditions. On exposure to caspofungin, both ADH1 and
ADH2 were down-regulated potentially resulting in ACH accu-
mulation. This down-regulation correlates with the results of a
previous study on 30 h C. albicans biofilms [73]. The positive
correlation between expression of ADH1 and ADH2 seen in this
study implies a functional role of Adh2p alongside Adh1p. This
finding is in line with previous work on planktonic cultures in
hypoxia [25]. The highest levels of ADH1 expression were
observed after exposure to PBS, HICA and cysteine and mainly
at acidic pH. Gene expression from PBS biofilms reflected an
induction of fermentation and pyruvate bypass as many genes in
the pathway were highly expressed. Considering the toxicity of
HICA and cysteine particularly at acidic pH, the up-regulation of
ADH1 and ALD5 could be a response to oxidative stress and
impairment of other respiratory functions. Interestingly, up-
regulation of ADH1 has been noted in apoptosis [74]. The
significantly high basal expression of ADH1 and ALD5 in this study
highlights their role in biofilms and supports the findings by others
in vitro and in vivo [30,31,36].
Alcohol abuse is the main etiologic agent in upper digestive tract
carcinogenesis and multiple studies by our group and others have
shown that the carcinogenic effect of alcohol is a result of
microbial metabolism of ethanol to ACH in vitro and in vivo [18,75–
77]. Also, marked production of ACH by Candida spp. from D-
glucose has been shown in vitro [15,18]. Considering that infections
are mostly biofilm-related and to support our hypothesis of the
carcinogenicity of Candida infection, it was important to elucidate
the mutagenic potential of C. albicans biofilms and the expression of
genes related to ACH and ethanol. Mutagenic levels of ACH were
produced by control biofilms during incubation in D-glucose at
neutral pH (up to 54 mM). No ACH was produced by biofilms
exposed to HICA during D-glucose incubation at acidic pH. At
neutral pH, the ACH levels were significantly lower compared to
control (RPMI) conditions and below the mutagenic level (,
40 mM). At neutral pH, ACH production from ethanol or D-
glucose by mature biofilms was decreased similarly by both HICA
and caspofungin. Interestingly, although caspofungin inhibited
ACH production by early biofilms more than HICA, it resulted in
the highest ACH levels at acidic pH during D-glucose incubation.
This is relevant as a normal western diet is often rich in D-glucose
and the 100 mM concentration used in this study is equivalent to
18 g/l found commonly in food and beverages. In the presence of
ethanol, ACH levels produced by all biofilms exposed to HICA or
caspofungin were generally lower than in control biofilms. The
ethanol concentration of 11 mM used in this study is found in
saliva after drinking 0.5 g of alcohol per kg body weight, which is
equivalent to 3 glasses of wine for an 80 kg male and thus can be
considered clinically relevant. Our results on biofilms support
earlier studies on planktonic cell cultures [12,15,18,77]. Biofilms
exposed to RPMI and ethanol produced high levels of ACH from
ethanol (up to 135 mM), well above the mutagenic level, and
approaching the results obtained with planktonic cultures. It is
relevant to point out that the highest ACH levels were produced at
later stages of biofilm growth, as would be established in niches of
the human body.
HICA was most active against C. albicans biofilms at acidic pH,
in line with previous studies where planktonic cultures were used
[43,44]. The main focus of the present study was to investigate the
anti-biofilm efficacy of HICA against various comparators
whereby it was critical to grow the biofilms under standardised
conditions before treatment at acidic and neutral conditions.
Therefore, the biofilms were not pre-grown at acidic conditions,
which can be considered a limitation: there are multiple sites that
are physiologically acidic and pH can have an effect on C. albicans
morphology [78]. On the other hand, acidic pH may favour
fungal over bacterial growth as seen in Candida esophagitis,
vulvovaginal candidosis and chronic wounds [79–83]. Interesting-
ly, the final metabolic activity and biomass of untreated (RPMI)
control biofilms after 24 h exposure to pH 5.2 and 7.4 were
comparable in the present study.
A recent report suggested that composition of the medium has a
major effect on biofilm architecture, expression profiles and
antifungal susceptibility [84]. In RPMI medium, the D-glucose
concentration of 2.0 g/l is higher than the physiological concen-
tration normally found in the human body (0.7–1.0 g/l; [85]).
Thus adjustment of the D-glucose concentration could bring the in
vitro models closer to physiological conditions in the human body
and allow for the discovery of the effects that may be masked by
the artificially high D-glucose concentrations used in vitro. Also a
major disadvantage of our study and multiple others is the use of
only one strain. There are major differences between clinical and
reference strains with respect to metabolic activity, susceptibility
profiles and the ability to form biofilms which suggests this analysis
would benefit by confirmation with clinical isolates [86]. It is
important to note that ACH levels were not standardised to cell
count or biomass but per biofilm unit. This was in order to avoid
potential artifacts that would arise through biofilm killing by
antifungal agents.
The mode of action for HICA is still unknown, and broader
transcriptional and proteomic studies are warranted to elucidate
the specific factors underlying its anti-microbial activity. Consid-
ering the similar expression of ACH catabolism genes after
cysteine and HICA exposure, cysteine may provide clues in the
quest to understand the mode of action of HICA. A few
Lactobacillus-fungus co-culture studies with a transcriptomic
approach have already shed light on this inhibitory mechanism
and they indicate a global metabolic shutdown in fungal cells in
response to Lactobacillus metabolites [50,52]. Considering the
urgent need for effective treatment strategies against fungal
infections, HICA could provide an alternative and effective
approach in the fight against superficial Candida biofilm infections
in concentrations relevant to topical treatment or lock therapies.
Together with its broadly antibacterial activity it could also be a
good choice for mixed bacterial-fungal infections. The decreased
mutagenic potential observed in biofilms exposed to HICA would
suggest that long-term therapy would not cause harmful exposure
of adjacent mucosa and surrounding bacteria to mutagenic ACH
although more studies are required to confirm this.
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